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Abstract
Outer membrane vesicles (OMV) contain immunogenic proteins and contribute to in vivo survival and virulence of bacterial
pathogens. The first OMV vaccines successfully stopped Neisseria meningitidis serogroup B outbreaks but required
detergent-extraction for endotoxin removal. Current vaccines use attenuated endotoxin, to preserve immunological
properties and allow a detergent-free process. The preferred process is based on spontaneously released OMV (sOMV),
which are most similar to in vivo vesicles and easier to purify. The release mechanism however is poorly understood
resulting in low yield. This study with N. meningitidis demonstrates that an external stimulus, cysteine depletion, can trigger
growth arrest and sOMV release in sufficient quantities for vaccine production (61500 human doses per liter cultivation).
Transcriptome analysis suggests that cysteine depletion impairs iron-sulfur protein assembly and causes oxidative stress.
Involvement of oxidative stress is confirmed by showing that addition of reactive oxygen species during cysteine-rich
growth also triggers vesiculation. The sOMV in this study are similar to vesicles from natural infection, therefore cysteine-
dependent vesiculation is likely to be relevant for the in vivo pathogenesis of N. meningitidis.
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Introduction
The release of outer membrane vesicles (OMV) is observed
among many bacterial species including gram-negative pathogens
like Escherichia coli, Vibrio cholerae, Salmonella typhimurium or Neisseria
meningitidis [1]. Pathogens produce OMV for in vivo survival,
virulence or interactions with the host immune system [2,3,4]. The
vesicles are spherical particles with a diameter of 50–200 nm,
containing a phospholipid bilayer with outer membrane proteins,
lipopolysaccharide (LPS or endotoxin) and a lumen with
periplasmic constituents [2,5]. N. meningitidis serogroup B epi-
demics in Norway, Cuba and New-Zealand were successfully
controlled with outer membrane vesicle vaccines, which was
a milestone for the application of OMV in vaccinology [6,7,8,9].
These vaccines however required extraction with a detergent
(deoxycholate), to decrease the amount of toxic LPS. The
detergent-extraction was effective but resulted in partially intact
and aggregated vesicles with an altered composition [10,11,12].
Discovery of the lpxL1 mutation successfully attenuated the LPS of
N. meningitidis and allowed the use of detergent-free OMV [13].
This provided vaccine concepts with equally low toxicity but
improved immunological and biochemical properties
[11,12,14,15]. Detergent-free OMV are more similar to in vivo
produced vesicles [5] and are now used for the development of
several next-generation vaccines against serogroup B meningo-
coccal disease [16,17,18,19,20].
There are two types of detergent-free OMV. The first type,
sOMV (spontaneously released OMV), is as similar to in vivo
vesicles as possible with a production system for human vaccines
[5]. The sOMV are released by the bacterium during in vitro
growth, without any treatments to enhance vesiculation [21,22].
The second type, eOMV (extracted OMV, also referred to as
native OMV) [15,17,23]), uses detergent-free extraction with
ethylene-diamine-tetraacetic acid (EDTA) to chelate calcium and
magnesium ions. This destabilizes the outer membrane which
enhances eOMV release and preserves the desired biochemical
and immunological properties, even though eOMV are not fully
identical to sOMV [11,24,25,26,27]. The properties do change
significantly when detergents are added to the extraction buffer.
The purification of eOMV is less straightforward than sOMV
purification due to more complicated handling (i.e. the extraction
step; Figure S1). New approaches that release sOMV in sufficient
quantities to compensate the EDTA extraction step are therefore
relevant for vaccine development.
Even though the existence of sOMV is known for decades, the
mechanism that triggers their release is not fully understood
[28,29]. A model was proposed for S. typhimurium in which the
density of associations between inner membrane, outer membrane
and peptidoglycan layer regulates vesicle release [2]. This model
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was in agreement with observations that disruption of trans-
membrane anchor genes increased vesiculation (i.e. tol, pal and
ompA in E. coli or rmpM in N. meningitidis) [11,30]. Not only physical
changes to the outer membrane but also external stimuli can
trigger sOMV release. For E. coli these stimuli include heat shock,
activitation of the envelope stress response pathway or lysine
depletion [31,32,33,34]. Such external triggers have not been
identified for N. meningitidis but recent work indicated that vesicle
yield increased significantly during stationary growth [23].
This study demonstrates that a novel external stimulus,
depletion of cysteine, can trigger the onset of stationary growth
and sOMV release by N. meningitidis. It is substantiated that
cysteine depletion causes oxidative stress as the intracellular signal
for increased vesiculation. The results also demonstrate that this
approach is applicable for vaccine production.
Results
Cysteine is the Growth-limiting Medium Component
Previous work showed that vesicle release by N. meningitidis
increased during the stationary growth phase [23]. To identify the
growth-limiting medium component of these experimental condi-
tions, nutrient consumption was monitored. Arginine and cysteine
were depleted upon onset of stationary growth, while the growth
medium still contained sufficient amounts of all other components
(data not shown). Therefore, concentrations of arginine and
cysteine were lowered systematically to identify the growth-
limiting component (Figure 1). Control medium with normal
amounts of cysteine and arginine produced regular growth curves
in shake flasks (exponential growth; dry biomass yield
3.960.1 gdw/L). Medium with normal cysteine but half the
normal amount of arginine gave identical growth (exponential;
4.260.3 gdw/L), indicating that less arginine did not have an
effect on growth. Media with half the amount of cysteine however
produced half the amount of biomass, regardless the amount of
arginine (1.960.1 gdw/L and 2.160.1 gdw/L for normal and low
arginine, respectively). Nutrient analysis confirmed that cysteine
was indeed depleted upon onset of stationary growth for all 4
media, while arginine depletion ocurred at a different time point
(Figure S2). These results indicate that cysteine, not arginine, is the
growth-limiting component of the medium.
Transcriptome Analysis Identified 149 Cysteine Regulated
Genes
Transcriptome analysis was performed with DNA microarrays
to identify genes that are regulated after cysteine depletion.
Growth and cysteine availability of triplicate cultivations on
normal growth medium were monitored. Transcriptome analysis
was performed on samples at 22.5, 21.4 and 20.4 hours (before
cysteine depletion) and at +1.4 and +3.5 hours (after cysteine
depletion). Principal component analysis on the full transcriptome
confirmed high reproducibility of replicates (Figure S3A). The
experimental treatment (cysteine depletion) accounted for 70% of
total gene expression variation and resulted in 2 distinct groups on
the first principal component axis (PC1; corresponding to ‘before’
and ‘after’ cysteine depletion). PC2 explained 7% of all variation
and the other principal components ,5%, indicating that
additional effects had only a minor impact on overall gene
expression. Subsequent statistical analysis selected 149 significantly
regulated genes (Fold Ratio .2.0 and False Discovery Rate
,0.10). Upon cysteine depletion, 90 genes were upregulated and
48 were downregulated. A variable expression pattern was
observed for 11 genes (Figure S3B).
The Gene Expression Profile of Cysteine Depletion
Resembles (Oxidative) Stress and Virulence
Cysteine regulated genes were compared with available
literature. Genes from a heat shock study [35] had significant
overlap with peroxide stress [36] (p,0.0001; binomial distribution
probability). Since both studies investigated stress stimuli they were
compiled into a single group (‘stress’) for the comparison with
cysteine depletion. In addition, studies on iron depletion [37] and
two host interaction studies [38,39] were compiled to ‘virulence’
based on significant overlap (p,0.0001). Studies on restrictive
oxygen conditions [40] and putative pathogenicity genes [41] were
not used due to insufficient overlap with cysteine regulated genes
and/or available literature. The compiled gene sets ‘stress’ and
‘virulence’ were then compared with the cysteine depletion genes,
revealing a significant overlap between the 3 groups (p,0.0001).
The overlap indicates that similar mechanisms may be involved in
these biological events (Figure 2A). Functional annotation of 149
cysteine regulated genes revealed 36 enriched Gene Ontologies
(p,0.05), related to 11 functional groups (Figure 2B). Functional
groups with distinct expression patterns were sulfur metabolism
(9/9 genes upregulated), iron-sulfur cluster (6/6 upregulated),
translation (13/16 downregulated), metal ion uptake (11/16
upregulated), cell wall (3/3 downregulated) and stress (2/2
upregulated). Non-distinct patterns were observed for redox (27
genes), membrane transport (23 genes), amino acid biosynthesis
(10 genes), energy metabolism (4 genes) and other functions (19
genes). Some functional groups were directly related to the
experimental context, like sulfur metabolism and amino acid
biosynthesis (cysteine depletion), downregulated translation ma-
chinery (stationary growth) or membrane transport (upregulated
sulfate uptake genes). The remaining functional groups were
Figure 1. Cysteine is the growth-limiting medium component.
Previous work demonstrated that vesicle release by N. meningitidis
increased during the stationary growth phase [23]. Nutrient analysis of
the chemically defined medium indicated that only arginine and
cysteine were depleted during early stationary growth. Therefore,
concentrations of both components were systematically lowered to
identify the growth-limiting nutrient. Black lines and black intersected
lines represent growth curves on media with normal and low arginine
concentration, respectively. Normal and low cysteine concentrations are
marked with circles and triangles. Cultivation time t = 0 represents the
expected onset of stationary growth on reference medium with normal
amounts of cysteine and arginine. The results indicate that cysteine, not
arginine is the growth-limiting component. See Figure S2 for
corresponding nutrient data.
doi:10.1371/journal.pone.0054314.g001
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primarily related to oxidative stress (redox, iron-sulfur cluster,
metal ion uptake and stress). Details are listed in Table S1.
Cysteine Depletion Triggers Increased sOMV Release
Based on the transcriptome results it was hypothesized that in
addition to growth arrest, cysteine depletion causes oxidative stress
as an intracellular signal for sOMV release. The hypothesis was
verified with a medium repletion experiment in shake flasks
(Figure 3). Precultures on control medium with the normal
amount of cysteine were pooled and repleted with control medium
or medium without cysteine (two groups). A third group was
repleted with control medium but growth was repressed with
peroxide to induce oxidative stress. Repleted cultures were
monitored for growth and sOMV release. The sOMV were
measured in small culture supernatant samples (sterile filtered;
,3 mL) with a fluorescent probe that specifically binds phospho-
lipid bilayer structures. Biomass concentration of the pooled
preculture (0.78 gdw/L) was comparable to the biomass density
directly after repletion (0.7660.05 gdw/L), indicating that no
biomass losses ocurred during the repletion procedure. Shake
flasks that were repleted with control medium continued growth to
a final dry biomass concentration of 3.7560.02 gdw/L. Cysteine
depleted and oxidative stress shake flasks did not grow, resulting in
final biomass concentrations of 0.6460.01 and 1.2860.20 gdw/L,
respectively (Figure 3A). The sOMV results however revealed
opposite effects. Control shake flasks grew normally but had a low
specific sOMV yield of 1.160.2 mg PorA antigen/gdw, while the
cysteine depleted shake flasks yielded 13.761.3 mg PorA/gdw
(with a constant sOMV release rate). Oxidative stress shake flasks
temporarily released sOMV after each peroxide addition (variable
sOMV release rate) resulting in an intermediate yield (7.760.8 mg
PorA/gdw; Figure 3B). Shake flasks were harvested before cysteine
in the control medium was exhausted, to prevent unintended
sOMV release. Integrity of sOMV in the culture supernatant was
confirmed with dynamic light scattering (DLS), which measured
a distinct peak around 100 nm indicating that the bacteria were
not desintegrating while releasing the OMV (data not shown). The
above results demonstrate that cysteine depletion triggers in-
creased sOMV release. Other stress stimuli like growth repression
with peroxide can mimic this effect.
Cysteine Depletion Approach is Feasible for sOMV
Vaccine Production
The shake flask repletion experiment measured sOMV yield
directly in the supernatant without taking purification losses or
vaccine quality into account. To assess whether the cysteine
depletion approach was feasible for vaccine production, larger
samples (250–400 mL) were taken from a bioreactor system to
purify eOMV (reference vaccine) and sOMV (experimental
vaccine) in parallel, according to the protocol in Figure S1.
Purifications were done at several time points before and after
cysteine depletion. The cultivations were monitored to measure
biomass concentration and cysteine (time points A to N). As
observed in shake flasks, biomass growth during the exponential
phase was reproducible for all 6 replicate bioreactor cultivations
(R2 = 0.975) and growth arrest ocurred upon cysteine depletion
(time point G; Figure 4A).
Purification of eOMV and sOMV vaccines was performed at
time points D, F (before) and I, K, M (after cysteine depletion).
Yield of purified eOMV (reference) correlated to the amount of
biomass that was used, resulting in a constant amount of
6.360.3 mg PorA antigen/gdw regardless nutrient availability
(Figure 4B). Yield of purified sOMV however depended on
cysteine availability. Before depletion the yield was just above
detection limit (0.260.1 and 0.360.1 mg PorA/gdw, respectively).
Cysteine depletion then triggered sOMV release resulting in
a cumulative increase during time point I (0.960.4 mg PorA/
gdw), time point K (2.060.4 mg/gdw) and time point M
(4.361.4 mg/gdw). The reference yield (eOMV) was significantly
Figure 2. The gene expression profile of cysteine depletion resembles (oxidative) stress and virulence. Intracellular effects of cysteine
depletion were explored with transcriptome analysis, resulting in 149 significantly regulated genes. (A) Significant overlap is found (p,0.0001)
between cysteine regulated genes and relevant literature (compiled gene sets ‘stress’ [35,36] and ‘virulence’ [37,38,39]), indicating that similar
mechanisms are involved in these different stimuli. (B) Functional annotation of cysteine regulated genes identified 36 enriched Gene Ontologies
(p,0.05) from 11 functional groups. In addition to expected groups like sulfur metabolism or translation, several functional groups are related to
oxidative stress (i.e. redox or iron-sulfur cluster). Therefore it is hypothesized that cysteine depletion impaires the sulfur supply for iron-sulfur protein
biogenesis, ultimately resulting in oxidative stress. Details of the transcriptome analysis are provided in Figure S3 (principal component analysis and
gene clustering) and Table S1 (expression data with functional annotation).
doi:10.1371/journal.pone.0054314.g002
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higher than sOMV at most time points (D, F, I and K; p,0.001)
but no significant difference was found at time point M, indicating
that the cysteine depletion approach can generate sufficient sOMV
for feasible vaccine production. Protein composition and vesicle
size distribution were measured to assess vaccine quality. Purified
eOMV had a comparable overall protein compositon at all time
points, with a high PorA antigen content (6463% of total protein;
Figure 5A). Purified sOMV were comparable to eOMV at time
points F, I, K and M (PorA content 6165%), but time point D had
a low and variable purity (43623%) caused by a yield that was
below the threshold for reliable analysis. Vesicle size averages of
eOMV (reference) and sOMV samples were comparable (8365
and 9769 nm respectively). The sOMV samples however had
a slightly broader size distribution and contained minor particle
peaks at ,5 mm, indicating that the purification procedure may
require improvements (Figure 5B).
Discussion
This study with Neisseria meningitidis demonstrates that cysteine
depletion can trigger growth arrest and the release of outer
membrane vesicles (OMV) in sufficient quantities for vaccine
production. The vesicles are released spontaneously (sOMV) and
are as similar to in vivo vesicles as possible with a production system
for human vaccines [5]. Therefore the obtained results may be
relevant for the in vivo vesiculation and pathogenesis of N.
meningitidis. To our knowledge, external stimuli that trigger sOMV
release were not previously described for N. meningitidis or for
cysteine as the limiting nutrient. Cysteine was found to be the
growth-limiting component of human serum when supplemented
to a chemically defined medium [42]. In serum-free media, some
strains had an absolute cysteine requirement but others were able
to grow on a variety of sulfur sources after adaptation [43,44]. The
vaccine production strain in this study is unable to adapt its sulfur
metabolism after cysteine depletion, resulting in stationary growth
despite a genetic ability to use alternate sulfur sources from the
medium (Figure 1). The strain has specific mutations to express
multiple protective PorA antigens, attenuate LPS toxicity and
improve OMV yield, which are required for detergent-free
vaccine production [11]. These mutations however may cause
an inability to adapt to cysteine depleted conditions, since previous
work with a strain that resembled the H44/76 parent strain more
closely did not reveal an absolute cysteine requirement for growth
[45].
Nutrient depletion was not previously associated with increased
sOMV release by N. meningitidis, but specific genetic modifications
are known to have a comparable outcome. The strain in this study
has a disrupted rmpM gene to prevent anchoring of the outer
membrane to the peptidoglycan layer with an OmpA-like domain
[11,46,47]. The gna33 mutation increases vesiculation through an
unknown mechanism [12]. External stimuli for vesiculation have
been identified in E. coli, including heat shock, lysine depletion or
conditions that activate the sE envelope stress response pathway
[31,32,33,34]. In agreement with these observations, this study
identified an external stress stimulus for N. meningitidis vesiculation.
It remains unknown to what extent the current results are
restricted to cysteine as the depleted nutrient or to this specific N.
meningitidis strain.
Transcriptome analysis was performed to elucidate the in-
tracellular effects of cysteine depletion in more detail. The
transcriptome profile resembles studies with N. meningitidis that
investigated stress [35,36] and virulence stimuli [37,38,39]
(Figure 2). Functional annotation revealed several pathways that
are directly related to cysteine depletion or a decreased growth
rate. The remaining pathways are related to oxidative stress, with
a central role for iron-sulfur protein biogenesis. Iron-sulfur
proteins are highly conserved in prokaryotes and eukaryotes.
Mutants with an impaired biogenesis accumulate free intracellular
Figure 3. Cysteine depletion triggers sOMV release. The effect of cysteine depletion on sOMV release is demonstrated with a repletion
experiment in shakeflasks. (A) Pre-cultures are grown on control medium with cysteine (circles). Harvested cells are repleted with control medium
(circles) or medium without cysteine (triangles). Shake flasks without cysteine enter the stationary phase, while cysteine repleted flasks continue
growth normally. A third group (squares) is repleted with control medium, but growth is repressed with peroxide to mimic oxidative stress and verify
the transcriptome data (arrows indicate peroxide additions). Y-axis represents dry biomass concentration (g dry weight per L). (B) Vesicle release in
the cultivation supernatant is monitored with a fluorescent probe up to 6 hours after repletion. Shake flasks with control medium grow normally but
do not release sOMV, while cysteine depletion triggers a sustained release of vesicles. Oxidative stress has a similar but transient effect, since sOMV
are released temporarily after each peroxide addition. Cysteine depletion is therefore an external stimulus for sOMV release, which induces oxidative
stress as the intracellular signal. Y-axis represents specific sOMV yield (mg PorA antigen per g dry weight).
doi:10.1371/journal.pone.0054314.g003
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iron and produce reactive oxygen species (ROS), which causes
oxidative stress [48,49]. In addition, iron-sulfur protein biogenesis
requires sulfur acquisition and storage protein for free iron
[50,51]. These aspects are all represented by genes that are
upregulated after cysteine depletion, including iron-sulfur cluster
assembly (erpA, nifU), cysteine synthase/desulfurase (cysK, iscS),
storage of Fe2+ ions (bfrA), ROS scavenging (sodB, sodC) and several
reductases. Therefore it is hypothesized that impaired iron-sulfur
protein biogenesis also occurs in N. meningitidis after cysteine
depletion, causing increased intracellular iron levels and oxidative
stress.
Recent work by our group showed that sOMV release by N.
meningitidis increased significantly during the stationary growth
phase, but the mechanism was not fully understood [23]. By
comparing cysteine repleted with depleted conditions, this study
demonstrates that cysteine depletion is the trigger for onset of
stationary growth and increased sOMV release (Figure 3). It also
shows that growth repression with oxidative stress, the hypothe-
sised outcome of cysteine depletion, mimics this effect temporarily.
Release of sOMV increases directly after each peroxide addition
but then stabilizes, while cysteine depletion results in sustained
vesicle release. Also, the peroxide dose range is narrow and critical
Figure 4. Implications for vaccine development. A novel
approach for the production of sOMV vaccine against N. meningitidis
serogroup B is explored by utilizing the effect of cysteine depletion. (A)
Biomass concentration (closed circles) is monitored in bioreactor
cultivations (time points A to N). Time point G marks onset of
stationary growth, caused by depletion of cysteine (open circles). (B)
Yield of purified sOMV vaccine (black bars) is compared with eOMV
reference vaccine, which uses detergent-free biomass extraction to
improve yield (white bars). Several time points before (D, F) and after (I,
K, M) cysteine depletion are included. After cysteine depletion, sOMV
yield increases gradually to quantities that are comparable to the eOMV
reference (no significant difference at time point M). Significant yield
differences are indicated with asterikses (p,0.05). ‘NS’ indicates a non-
significant difference.
doi:10.1371/journal.pone.0054314.g004
Figure 5. Quality of sOMV and eOMV vaccines. In addition to
yield, quality of the sOMV and eOMV vaccines is compared. It was
previously demonstrated that both vaccine types provide low toxicity
and high functional immunogenicity in mice [11]. (A) Protein
composition of eOMV reference vaccines is comparable to sOMV
vaccines after cysteine depletion (time points I, K, M). Each lane contains
4 mg total protein, except sOMV at time points D and F (low protein
concentration due to a low yield; maximal sample volume is loaded).
PorA antigen (,41 kD) has a major contribution to total protein
content (.60%) in all vaccines. (B) Dynamic light scattering analysis
reveals that sOMV vaccines have a slightly broader size distribution and
minor aggregation compared to the eOMV references, indicating that
the purification procedure is not yet fully consistent. X-axis represents
vesicle size distribution (nm).
doi:10.1371/journal.pone.0054314.g005
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for bacterial viability (data not shown). Despite these limitations,
the results confirm involvement of oxidative stress as an in-
tracellular signal for sOMV release and support the transcriptome
data. N. meningitidis encounters oxidative stress in vivo, when
phagocytes use ‘oxidative burst’ to eliminate the invading
pathogen [52,53]. In such conditions vesiculation may provide
decoys for phagocytosis and enhance bacterial survival.
This study provides a novel approach for the production of
sOMV vaccine against N. meningitidis serogroup B, in which onset
of stationary growth and vesiculation is determined by the cysteine
concentration of the growth medium. The use of a synthetic
medium with a single growth-limiting component greatly improves
process control. Other media for N. meningitidis have unidentified
limiting nutrients and contain undefined components like
casamino acids, resulting in less predictable growth
[10,17,54,55]. Purification of sOMV does not require concentra-
tion, resuspension or extraction of the bacterial biomass (Figure
S1). These steps are labour intensive and complicate processing,
especially when translated to large-scale processes. Therefore
sOMV purification is the preferred approach for process de-
velopment. To assess feasibility, yield and quality of sOMV
vaccines were compared with eOMV references at several time
points before and after cysteine depletion. In agreement with the
initial observations (Figure 3), sOMV release is triggered after
cysteine depletion and then increases over time. Final yield is
comparable to the eOMV reference, indicating that cysteine
depletion can also provide a feasible yield (Figure 4; 61500
human doses sOMV vaccine per L cultivation). The sOMV have
a slightly broader size distribution, indicating that the purification
procedure is not yet fully consistent. This procedure may improve
by replacing the centrifugal ultrafiltration units with more robust
and scalable equipment like tangential flow ultrafiltration [56].
In conclusion, this study shows that cysteine depletion can
trigger growth arrest and outer membrane vesicle release by N.
meningitidis. Transcriptome data suggests a relation between
cysteine depletion and impaired iron-sulfur protein assembly,
resulting in oxidative stress. This hypothesis is substantiated by
showing that induced oxidative stress during cysteine-rich growth
also triggers vesiculation. Cysteine depletion improves the pro-
duction of a vaccine against serogroup B meningococcal disease,
resulting in substantial amounts of sOMV. Since the sOMV are
more similar to vesicles from natural infection, cysteine-dependent
vesiculation is likely to be relevant for the in vivo pathogenesis of N.
meningitidis.
Materials and Methods
Bacterial Strain and Shake Flask Cultivations
The N. meningitidis vaccine strain that was used is a recombinant
variant of serogroup B isolate H44/76 [57], combining one wild-
type and two recombinant PorA antigens (trivalent PorA; subtypes
P1.7,16; P1.5–1,2–2 and P1.19,15–1) with a non-functional porB
gene [58]. The cps locus was deleted, resulting in a non-
encapsulated phenotype with galE-truncated LPS. Additional
deletions in lpxL1 and rmpM genes attenuate LPS toxicity and
improve yield [11]. All cultures were grown in chemically defined
growth medium [59]. For shake flask cultivations, 150 mL pre-
culture was inoculated with 10 mL working seedlot (cells at
OD590 = 1.560.1; stored at 2135uC with glycerol) and incubated
in 500 mL erlenmeyer shake flasks (Nalgene, Rochester NY,
U.S.A.) at 35uC, 200 rpm. At an OD590 of 1.560.3, 10 mL
portions from the pre-culture shake flask were used to inoculate
several secondary shake flasks, containing media with different
arginine and cysteine concentrations (for Figure 1). Alternatively,
secondary shake flasks with normal medium were grown to an
OD590 of 2.560.3 for repletion experiments (for Figure 3). Shake
flasks for Figure 3 were pooled and centrifuged in 150 mL portions
(20 min.; 30006g; 4uC). Pellets were resuspended, washed in
75 mL medium (with/without cysteine) and re-centrifuged. The
depletion/repletion experiments started after resuspending the
pellets in 150 mL medium with/without cysteine. To induce
oxidative stress, 150 mM peroxide was added to each shake flask
(triplicates) directly after depletion/repletion (t = 0). Growth was
then monitored with hourly OD590 measurements. If the average
optical density increased .10% between 2 measurements, 50 mM
peroxide was added to repress growth. This was necessary at
t = 2.5 and 5.5 hours after depletion/repletion (arrows in Figure 3).
Bioreactor Cultivations
Transcriptome analysis (Figure 2) and OMV production
(Figure 4) was performed on samples from a fully instrumented,
5 L benchtop bioreactor (Applikon, Schiedam, The Netherlands)
with 6-blade Rushton impeller for mixing and gas dispersion and
initial working volume of 3.5 L. Controller set points were
35.060.5uC (temperature), 3065% (dissolved oxygen concentra-
tion), 7.260.1 (pH), 300–750 rpm (stirrer speed). The bioreactor
was inoculated with 150 mL pre-culture at OD590 = 1.560.3. The
bioreactor was connected to an ADI-1040 control system
(Applikon), operated with BCSV software (Compex, Gent,
Belgium). After inoculation, dissolved oxygen concentration was
first controlled by gradually increasing stirrer speed to 750 rpm.
Then the fraction of oxygen in the headspace increased gradually
while maintaining a constant total gas flow of 1.0 L/min. Samples
for nutrient analysis were sterile filtered (0.22 mm) and stored at
4uC.
Transcriptome Analysis
Transcriptome analysis was performed as described previously
[60,61]. RNA were analysed with a full-genome N. meningitidis
MC58 microarray [41], which covered 93% of predicted ORFs
(Operon, Ko¨ln, Germany). Oligonucleotides were spotted in
triplicate on UltraGAPS II coated slides (Corning, Corning NY,
USA). The transcriptome profile was preserved by mixing 1
volume of bacterial culture (corresonding to 2.5 mL at OD590 = 1)
with 2 volumes of RNA-later solution (Ambion, Paisley, United
Kingdom), then concentrated with centrifugation (20 min.;
30006g; 4uC) and stored at 280uC until RNA extraction.
Bacterial pellets were thawed and pre-treated in Tris-EDTA
buffer with 0.5 mg/mL lysozyme (Sigma–Aldrich, Zwijndrecht,
The Netherlands) prior to RNA extraction according to
manufacturer’s protocol (SV Total RNA isolation kit; Promega,
Fitchburg WI, USA). Nucleic acid concentration was adjusted with
ethanol precipitation and spectral analysis was used to determine
purity and concentration. RNA integrity was measured with the
Bioanalyzer RNA6000 Nano assay (Agilent Technologies, Santa
Clara CA, USA), according to the manufacturers’ protocol. RNA
integrity number (RIN) scores were used to assess RNA integrity
(score.8.0 required for inclusion) [62]. Total RNA from triplicate
samples at each time point were reverse transcribed to cDNA and
labelled with Cy3 dye using the Chipshot Indirect Labeling and
Clean-Up kit (Promega), according to the manufacturer’s protocol.
Common reference samples, containing equal amounts of total
RNA from all experimental samples, were labelled with Cy5. The
labelled and purified cDNA samples were pooled in Cy3/Cy5
pairs. Hybridization buffer was added to a final concentration of
25% formamide, 56 SSC and 0.1% SDS. Samples were applied to
the microarray slides and incubated in a hybridization chamber
(16–20 h; 42uC; dark). Differential gene expression was calculated
Cysteine Depletion Triggers OMV Release
PLOS ONE | www.plosone.org 6 January 2013 | Volume 8 | Issue 1 | e54314
through comparison with the common reference. Microarrays
were scanned with a ScanArray Express microarray scanner
(Perkin Elmer, Waltham MA, USA) and median fluorescence
intensities were quantified for each spot using ArrayVision
software (Imaging Research). The data was natural-log trans-
formed, quantile normalized and values of replicate spots were
averaged. These data processing steps were done with the
statistical software R, using an in-house developed script. P-values
were calculated with one-way ANOVA statistical analysis.
Significantly regulated genes were selected with a False Discovery
Rate (FDR) of ,10% to adjust p-values for multiple testing. Fold
ratio (FR) values were expressed as the natural log of the
normalized signal difference between the two groups. To further
select for biologically relevant effects, a FR threshold of .2.0
(untransformed value) was applied to obtain the final results. Gene
annotations were obtained from Uniprot Knowledge Base (www.
uniprot.org; N. meningitidis MC58; version July 2011). Principal
component analysis (PCA) and clustering of differentially ex-
pressed genes in expression groups was performed with Gene-
maths XT software (Applied Maths, Sint-Martens-Latem, Bel-
gium). Overall gene expression differences between samples were
assessed by calculating the Euclidian distance between gene
expression values over the entire set of genes (this corresponds to
the distance in a PCA plot). Functional annotations of cysteine
regulated genes were retrieved from the Gene Ontology database,
using corresponding Uniprot protein IDs (www.geneontology.org;
version February 2012). Enrichment for a specific Gene Ontology
was assessed by comparing the number of hits in the cysteine
dataset with the number of hits in the MC58 genome. Enrichment
p-values were obtained by calculating the binomial distrbution
probability. The binomial distribution probability was also used to
calculate a p-value for the overlap between gene lists, allowing
comparison of the cysteine dataset with relevant literature.
OMV Purification and Characterization
This study used small-scale, detergent-free OMV purifications
as described previously [11]. Cultivation samples (250–400 mL)
were taken from the bioreactor and purified. The samples were
split in supernatant (sOMV) and pellet (eOMV) with centrifuga-
tion (20 min.; 30006g; 4uC). To purify sOMV, supernatant was
sterile filtered (0.22 mm) and concentrated with ultrafiltration (UF),
using centrifugal units with 100 kD cutoff (Centricon 70-plus
Ultracell, Millipore, Billerica MA, USA). UF units were washed
with saline, filled with 70 mL supernatant and concentrated to 10–
15 mL by centrifugation. The retentate was re-diluted to 70 mL
with fresh supernatant and the cycle was repeated until the full
sample was processed (centrifugation at 15006g; 4uC). Final
retentate was diluted to 70 mL with storage buffer and concen-
trated to 10 mL (first wash step). The sOMV in the retentate were
then pelleted with ultracentrifugation (120 min.; 1250006g; 4uC)
and resuspended in a suitable volume of storage buffer (second
wash step). To purify eOMV, the bacterial pellet was resuspended
in 7.5 volumes (mL/g wet weight) of EDTA buffer (100 mM Tris-
HCl pH8.6 with 10 mM EDTA) and incubated (30 min. ambient
temperature). Cells were discarded by semi high-speed centrifu-
gation (75 min.; 200006g; 4uC). Ultracentrifugation was used to
pellet eOMV in the supernatant (120 min.; 1250006g; 4uC) and
the pellet was resuspended in a suitable volume of storage buffer.
Final total protein concentration was 1.060.5 mg/mL for all
OMV samples. Total protein concentration, PorA quantity and
vesicle size distribution of OMV samples were performed as
described previously [11,63]. Briefly, total protein concentration
was measured with the Lowry protein assay. Peterson’s modifica-
tion was used to reduce the effect of interfering substances. PorA
antigen content was determined by SDS gel electrophoresis,
followed by total protein staining and quantification of the 40–
44 kD bands (PorA). Gels were stained with Novex Colloidal Blue
(Invitrogen, Breda, The Netherlands) and PorA was quantified as
a percentage of total protein using TL100 1D gel analysis software
(Totallab, Newcastle upon Tyne, U.K.). Vesicle size distribution
was measured with dynamic light scattering (DLS) at 25uC with
a Malvern 4700 system. Homogeneity of the vesicle size
distribution was reflected in the polydispersity index (PdI), which
ranges between 0.0 (fully homogeneous size distribution) and 1.0
(random size distribution).
Quantification of Nutrients and sOMV Release
Cysteine (after reaction with bromoacetic acid and reduction
using tris(2-ethylcarboxy)phosphine (TCEP)) and arginine were
quantified by HPLC after derivatisation with orthophtalic
anhydride (OPA). Release of sOMV in the culture supernatant
was monitored by using the fluorescent signal of a phospholipid-
specific probe (SynaptoRed C2, Biotium, Hayward, CA, USA;
ex500, em650). An aqueous solution of SynaptoRed C2
(0.05 mM, 50 mL) was mixed with 50 mL of sterile filtered culture
supernatant or OMV standard with a known concentration.
Fluorescence of the resulting mixture was recorded in black
microtiter plates using a fluorometer (Synergy MX microplate
reader; Biotek, Bad Friedrichshall, Germany). A calibration curve
was constructed from the responses of the standards (dilutions of
purified eOMV standard corresponding to 0–10 mg/L PorA
antigen). Concentration of sOMV in culture supernatant samples
was calculated from this calibration curve.
Supporting Information
Figure S1 Detergent-free OMV purification. There are
two different detergent-free OMV purification types; sOMV
(spontaneously released OMV) are purified from the culture
supernatant without additional treatments to enhance vesicle
release, while eOMV (extracted OMV) are obtained after
detergent-free extraction of the bacterial biomass with a chelating
agent (EDTA). Therefore both OMV types can be purified in
parallel from a single cultivation. This study uses eOMV as
a reference for high yield and quality [23]. Cultivation harvest was
split in supernatant and bacterial pellet with low speed
centrifugation. The supernatant was sterilized with filtration, then
sOMV were concentrated with ultrafiltration and pelleted with
ultracentrifugation. Purified sOMV were resuspended in a suitable
volume of storage buffer. The bacterial pellet was resuspended in
EDTA extraction buffer to release eOMV. Cells were incubated
and discarded with semi high-speed centrifugation. Ultracentrifu-
gation was used to concentrate eOMV and the pellet was
resuspended in a suitable volume of storage buffer. Purification
of eOMV requires several complicated steps in terms of handling
(concentration, resuspension and extraction of the bacterial
biomass). Therefore sOMV purification is the preferred approach
for process development.
(PDF)
Figure S2 Nutrient monitoring identifies the growth-
limiting medium component. Media with different combina-
tions of cysteine (cys) and arginine (arg) are tested to determine the
growth-limiting component. Upper plots represent nutrient
concentrations in media with normal cys, while the lower plots
represent media with low cys. Media with normal or low arg are
indicated with circles or triangles, respectively. Y-axes represent
cys concentration (plots on the left) or arg concentration (plots on
the right), The X-axis represents cultivation time, with t = 0 as the
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expected time point of growth arrest (confirmed for control
medium with normal amounts of cys and arg; upper left plot,
circles). Grey vertical lines indicate the observed growth arrest
time point (obtained from Figure 1). The results demonstrate that
growth arrest depends on cys availability and is independent of
arg.
(PDF)
Figure S3 Detailed transcriptome analysis. (A) Principal
component analysis was performed on the full transcriptome to
asses reproducibility of replicates and identify sources of variation
in the dataset (principal components, or PCs). The analysis shows
that PC1 and PC2 explain 70% and 7% of total variation in the
dataset, respectively, while the remaining PCs explained ,5%
each. PC1 represents cysteine availability because all samples
before depletion (t =22.5 h (white circles), t =21.2 h (grey
circles) and t =20.4 h (black circles)) have a high score, while
depleted samples (t =+1.4 h (white triangles) and t = +3.5 h (black
triangles)) have a low score. This indicates that the experimental
treatment accounts for the majority of variation in the data. All
biological replicates have comparable PC1 and PC2 coordinates,
indicating high reproducibility. (B) Significant effects in the dataset
were initially selected with a False Discovery Rate threshold (FDR
,0.10). To refine for biologically relevant effects, a Fold Ratio
filter was used (FR .2.0). Clustering of the resulting 149 cysteine
regulated genes reveals 3 expression groups: downregulated after
cysteine depletion (48 genes), upregulated after depletion (90
genes) and 11 genes with a variable expression pattern. For further
interpretation of the results, functional properties of the cysteine
regulated genes were assessed. This resulted in 36 enriched Gene
Ontologies (p,0.05) from 11 functional groups (Table S1).
(PDF)
Table S1 Cysteine regulated genes with functional
annotation. (A) List of all genes that are differentially expressed
after cysteine depletion. Each entry contains accession number,
gene name, gene symbol, expression data (pattern and statistics)
and details of the functional annotation (enriched Gene Ontology
numbers and corresponding functional groups). (B) Overview of
enriched Gene Ontologies in the cysteine depletion dataset. Each
entry contains Gene Ontology ID, name and corresponding
functional group. The statistics section shows the number of hits
for each Gene Ontology in the cysteine depletion dataset and the
total number of hits in the MC58 genome. Based on both counts,
an enrichment p-value is calculated by using the binomial
distribution probability. Only Gene Ontologies with significant
p-values (,0.05) are included in the list.
(PDF)
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